Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.

Leukemia - 1 May 2020

Liebers Nora, Roider Tobias, Bohn Jan-Paul, Haberbosch Isabella, Pircher Andreas, Ferstl Barbara, Ebnöther Monika, Wendtner Clemens-Martin, Dearden Claire, Follows George A, Ho Anthony D, Müller-Tidow Carsten, Dreger Peter, Troussard Xavier, Zenz Thorsten, Dietrich Sascha

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Imidazoles
Share to Leukemia, Hairy Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oximes

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins B-raf

Share to Survival Rate

Share to Vemurafenib

Source

Identifiers

PMID: 31740808
DOI: 10.1038/s41375-019-0646-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.PMID 31740808Read ↗

Non-V600E BRAF mutations and treatment for hairy cell leukemia.Semantic proximity Read ↗

BRAF inhibition in refractory hairy-cell leukemia.Semantic proximity Read ↗

Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment.Semantic proximity Read ↗

Hairy cell leukemia: Past, present and future.Semantic proximity Read ↗

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.Semantic proximity Read ↗

Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia.Semantic proximity Read ↗

Genomics of Hairy Cell LeukemiaSemantic proximity Read ↗

[Molecular and therapeutic advances in Hairy cell leukemia].Semantic proximity Read ↗

Efficacy of vemurafenib in hairy-cell leukemia.Semantic proximity Read ↗

Second hematologic malignancies in hairy cell leukemia: report of two patients with dynamic mutations in the BRAF gene.Semantic proximity Read ↗

BRAF mutation in hairy cell leukemiaSemantic proximity Read ↗

The Biology of Classic Hairy Cell Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.